Medical Device Network: C2N receives funding for Alzheimer’s disease testing platform

Written By Joni Henderson
Read more
Joni Henderson
Previous

Washington Post: Alzheimer’s patients and their families hear a new word: Progress
Next

NIH Research Matters: Accurate blood test for Alzheimer’s disease